Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DEGS1 | O15121 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.40 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6836721 | 0.90 | DEGS1 (0.50) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL1140287 | 0.90 | DEGS1 (0.50) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL11241457 | 0.79 | SMN1; SMN2 (0.57) | SMN1; SMN2LMNAHPGDALDH1A1GSK3B | |
| SCHEMBL11241460 | 0.79 | SMN1; SMN2 (0.57) | SMN1; SMN2LMNAHPGDALDH1A1GSK3B | |
| SCHEMBL582234 | 0.77 | NR4A2 (0.60) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL1536443 | 0.77 | NR4A2 (0.60) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL566350 | 0.77 | DEGS1 (0.53) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL566351 | 0.77 | DEGS1 (0.53) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL691911 | 0.77 | NR4A2 (0.60) | DEGS1SMN1; SMN2CES2CES1MEN1 | |
| SCHEMBL18570750 | 0.77 | DEGS1 (0.44) | DEGS1SMN1; SMN2CES2CES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068235-A1 | Individualizable dosage form | Searete LLC, a limited liability corporation of Deleware | 2010-03-18 | — | — | US | claimed |
| US-20140257841-A1 | EX VIVO MODIFIABLE MULTIPLE MEDICAMENT FINAL DOSAGE FORM | SEARETE LLC (US) | 2014-09-11 | — | — | US | disclosed |
| US-8753677-B2 | Ex vivo modifiable multiple medicament final dosage form | THE INVENTION SCIENCE FUND I, LLC (US) | 2014-06-17 | — | — | US | disclosed |
| US-20100068275-A1 | Personalizable dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068152-A1 | Ex vivo modifiable particle or polymeric based final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068153-A1 | Ex vivo activatable final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068278-A1 | Ex vivo modifiable medicament release-associations | SEARETE LLC, A LIMITED LIABLITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068283-A1 | Ex VIVO modifiable particle or polymeric material medicament carrier | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068256-A1 | Ex vivo modifiable medicament release-substance | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068266-A1 | Ex vivo-modifiable multiple-release state final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100069887-A1 | Multiple chamber ex vivo adjustable-release final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068277-A1 | Ex vivo modifiable multiple medicament final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100069821-A1 | Ex vivo modifiable medicament release-sites final dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068254-A1 | Modifying a medicament availability state of a final dosage form | THE INVENTION SCIENCE FUND I, LLC | 2010-03-18 | — | — | US | disclosed |
| US-20100069822-A1 | System for ex vivo modification of medicament release state | SEARETE LLC, A LIMITED LIABLITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-20100068235-A1 | Individualizable dosage form | Searete LLC, a limited liability corporation of Deleware | 2010-03-18 | — | — | US | disclosed |
| US-20100068233-A1 | Modifiable dosage form | SEARETE LLC, A LIMITED LIABILITY CORPORATION OF THE STATE OF DELAWARE | 2010-03-18 | — | — | US | disclosed |
| US-6174645-B1 | BIOCOMPATIBILITY; NONTOXIC; ANTICOAGULANTS | UNIVERSITY OF PITTSBURGH | 2001-01-16 | — | — | US | disclosed |
| US-5990193-A | A PHOTOSENSITIVE CROSSLINKED POLYMER NETWORK OF BRANCHED MACROMERIC POLYMERS FUNCTIONALIZED WITH PHOTOCHROMIC MOIETIES, PREFERABLY CINNAMYLIDENE; CYCLIZATION AND PHOTOSCISSION USING DIFFERENT WAVELENGTHS; BIODEGRADABLE ?BANDAGES? | UNIVERSITY OF PITTSBURGH (US) | 1999-11-23 | — | — | US | disclosed |